BlueCrest Capital Management’s AbbVie ABBV Stock Holding History

BlueCrest Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,400	Closed	-$1.79M	–	207
2023 Q4	$1.61M	Sell	10,400 -2,087	-17%	-$304K	0.06%	152
2023 Q3	$1.86M	Buy	12,487 +9,041	+262%	+$1.33M	0.08%	144
2023 Q2	$464K	Buy	+3,446	New	+$505K	0.02%	174
2020 Q1	–	Sell	-17,148	Closed	-$1.52M	–	215
2019 Q4	$1.52M	Buy	17,148 +11,838	+223%	+$983K	0.1%	128
2019 Q3	$402K	Buy	+5,310	New	+$364K	0.03%	300
2019 Q2	–	Sell	-23,200	Closed	-$1.87M	–	391
2019 Q1	$1.87M	Buy	+23,200	New	+$1.9M	0.07%	184
2018 Q4	–	Sell	-25,075	Closed	-$2.37M	–	818
2018 Q3	$2.37M	Sell	25,075 -37,926	-60%	-$3.6M	0.06%	223
2018 Q2	$5.84M	Buy	+63,001	New	+$6.15M	0.15%	150
2018 Q1	–	Sell	-47,767	Closed	-$4.62M	–	1452
2017 Q4	$4.62M	Buy	+47,767	New	+$4.5M	0.13%	158
2016 Q4	–	Sell	-5,458	Closed	-$344K	–	642
2016 Q3	$344K	Sell	5,458 -1,942	-26%	-$126K	0.01%	595
2016 Q2	$458K	Sell	7,400 -7,849	-51%	-$478K	0.02%	552
2016 Q1	$871K	Buy	+15,249	New	+$850K	0.05%	401
2015 Q4	–	Sell	-6,969	Closed	-$379K	–	953
2015 Q3	$379K	Sell	6,969 -4,117	-37%	-$268K	0.01%	653
2015 Q2	$745K	Buy	+11,086	New	+$724K	0.02%	548

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlueCrest Capital Management's ABBV Position: Q1 2024 in Review

BlueCrest Capital Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 10,400 shares — an estimated $1.79M sold.

BlueCrest Capital Management first reported a position in ABBV in Q2 2015 and held it in 14 quarters. The position peaked at $5.84M in Q2 2018. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

BlueCrest Capital Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
BlueCrest Capital Management sold 10,400 AbbVie shares in Q1 2024, an estimated $1.79M.
BlueCrest Capital Management first reported a position in AbbVie in Q2 2015 and held it in 14 quarters.
BlueCrest Capital Management's AbbVie position peaked at $5.84M in Q2 2018.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.